PHIA:EURONEXT AMSTERDAMKoninklijke Philips N.V. Analysis
Data as of 2026-03-10 - not real-time
€25.02
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Philips is trading below its short‑term moving average while staying above longer‑term averages, indicating a mixed technical picture. The RSI sits in a neutral zone and the MACD has turned bearish, suggesting short‑term downside pressure, yet the broader trend remains bullish and the stock is near a key support level.
Fundamentally, the company delivers solid margins and a respectable dividend yield, but a high payout ratio and elevated debt levels temper enthusiasm. Forward earnings estimates point to a notable improvement, narrowing the price‑to‑earnings gap and creating upside relative to analyst targets. The low beta underscores limited market‑wide volatility, though recent price swings have been pronounced. Overall, the blend of attractive yield, earnings acceleration, and undervalued valuation supports a cautiously optimistic stance.
Fundamentally, the company delivers solid margins and a respectable dividend yield, but a high payout ratio and elevated debt levels temper enthusiasm. Forward earnings estimates point to a notable improvement, narrowing the price‑to‑earnings gap and creating upside relative to analyst targets. The low beta underscores limited market‑wide volatility, though recent price swings have been pronounced. Overall, the blend of attractive yield, earnings acceleration, and undervalued valuation supports a cautiously optimistic stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- bearish MACD momentum
- recent earnings beat supporting confidence
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- forward earnings acceleration
- valuation upside relative to analyst targets
- attractive dividend yield despite payout concerns
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- secular demand for health‑technology solutions
- steady cash‑flow generation
- need to manage leverage and dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin5.02%
P/E Ratio26.9
ROE7.82%
ROA3.20%
Debt/Equity73.57
P/B Ratio2.2
Op. Cash Flow€1.2B
Free Cash Flow€453.0M
Industry P/E25.2
Technical Analysis
TrendBullish
RSI43.7
Support€24.06
Resistance€27.37
MA 20€26.16
MA 50€25.32
MA 200€23.44
MACDBearish
VolumeStable
Fear & Greed Index76.57
Valuation
Fair Value€1.35
Target Price€28.58
Upside/Downside14.21%
GradeUndervalued
TypeBlend
Dividend Yield3.42%
Risk Assessment
Beta0.25
Volatility41.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.